The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Cephalon ends program on Nuvigil as jet lag drug

December 27, 2010 6:45 am | by The Associated Press | News | Comments

Cephalon Inc. said Monday it will no longer pursue Food and Drug Administration approval of Nuvigil in a new use — as a treatment for jet lag — after new questions from and conversations with the agency.Nuvigil is approved as a treatment for tiredness caused by sleep apnea, narcolepsy, or...

Thermo Fisher completes Lomb Scientific purchase

December 27, 2010 6:45 am | by The Associated Press | News | Comments

Scientific instrument maker Thermo Fisher Scientific Inc. said Monday that it has completed its previously announced purchase of Lomb Scientific, which makes chemicals, consumables and instruments.Lomb, which has offices in Australia and New Zealand, has about 100 employees and reported about...

PSivida's eye drug target stalled by FDA

December 27, 2010 6:36 am | by Mass High Tech: The Journal of New England Technology | News | Comments

The U.S. Food and Drug Administration has rejected – for now – a New Drug Application for Watertown biotech pSivida Corp.'s eye disease drug Iluvien, licensed by Georgia-based Alimera Sciences Inc.


Market Publishers Ltd and GenericsWeb Sign Partnership Agreement

December 27, 2010 6:34 am | by Bio-Medicine.Org | News | Comments

LONDON, Dec. 27, 2010 /- Market Publishers Ltd and GenericsWeb Pty Ltd signed partnership agreement for quality market research promotion on Internet. is now authorized to distribute and sell GenericsWeb research reports . Mrs. Alla Martin, Head of Partner Relations...


K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission

December 27, 2010 6:34 am | News | Comments

ST. LOUIS, Dec. 27, 2010 /- K-V Pharmaceutical Company (NYSE: KVa/KVb) today announced the filing of its Form 10-K for its fiscal year ended March 31, 2010 with the Securities and Exchange Commission.  As a result, the Company has met the deadline for filing its delayed fiscal 2010...

Transition changes pact for Alzheimer's drug

December 27, 2010 4:45 am | by The Associated Press | News | Comments

Transition Therapeutics Inc. said Monday that Elan Corp. Plc modified their partnership on the potential Alzheimer's disease drug ELND005, giving Elan development responsibility.Under the changes, Elan will make a $9 million payment to Transition, in lieu of a required Phase 3 study milestone...

Generex extends deadline for Global Medical deal

December 27, 2010 4:38 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Worcester-based Generex Biotechnology Corp. has extended the closing date of its planned acquisition of 51 percent of Global Medical Direct LLC, a Kansas-based provider of diabetes supplies and medications.

PMA Final Decisions for October 2010

December 27, 2010 4:37 am | by U.S. Food & Drug Administration | News | Comments

These are Premarket Approvals (PMA), Product Development Protocols (PDP), Supplement and Notice Decisions for October 2010.


Football League Funds Medical School Inquiry

December 27, 2010 4:36 am | by San Diego Business Journal | News | Comments

NFL Charities, the philanthropic arm of the National Football League owners, has awarded more than $1.6 million in grants to support sports-related medical research organizations, including nearly $100,000 that will go to a team of researchers at UC San Diego School of Medicine.


Mindray Medical Announces Shareholder Resolutions Adopted at 2010 Annual General Meeting

December 27, 2010 4:34 am | by Bio-Medicine.Org | News | Comments

SHENZHEN, China, Dec. 27, 2010 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR ), a leading developer, manufacturer and marketer of medical devices worldwide, today announced shareholder resolutions adopted at its annual general meeting of shareholders held...


Federal Register: Circulatory System Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting

December 27, 2010 4:30 am | by U.S. Food & Drug Administration | News | Comments

On January 25, 2011, the committee will discuss and make recommendations regarding regulatory classification of Automated External Defibrillators to either reconfirm to class III (subject to premarket approval application (PMA)) or reclassify to class...


Cepheid Announces European Release of Xpert Flu, Delivering Simultaneous Detection and Differentiation of Flu A, Flu B, and 2009 H1N1 Strain

December 27, 2010 2:32 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Dec. 27, 2010 /- Cepheid (Nasdaq: CPHD ) today announced the release of Xpert® Flu as a European CE IVD Mark product under the European Directive on In Vitro Diagnostic Medical Devices. The test, which runs on Cepheid's GeneXpert® System, simultaneously...


Newborns with low vitamin D levels at increased risk for respiratory infections

December 26, 2010 8:32 pm | by EurekAlert | News | Comments

(Massachusetts General Hospital) The vitamin D levels of newborn babies appear to predict their risk of respiratory infections during infancy and the occurrence of wheezing during early childhood, but not the risk of developing asthma.


Microfluidic Device Rapidly Orients Hundreds of Fly Embryos

December 26, 2010 6:37 pm | by Georgia Tech Institute of Technology | News | Comments

Researchers have developed a microfluidic device that orients hundreds of fruit fly embryos to prepare them for research. The device could facilitate the study of such issues as how organisms develop their complex structures from single cells.

Georgia Tech Team Helps Decode Newly Sequenced Strawberry Genome

December 26, 2010 6:37 pm | by Georgia Tech Institute of Technology | News | Comments

Georgia Tech Regents professor Mark Borodovsky led efforts in identifying protein-coding genes in the newly sequenced woodland strawberry genome. The development is expected to yield tastier, hardier varieties of the berry and other crops in its family.


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.